Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 4;115(9):1843-9.
doi: 10.1182/blood-2009-07-231068. Epub 2009 Dec 22.

Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies

Juliet N Barker  1 , Andromachi Scaradavou, Cladd E Stevens
Affiliations

Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies

Juliet N Barker et al. Blood. .

Abstract

Both total nucleated cell (TNC) dose and human leukocyte antigen (HLA)-match affect the outcome of cord blood (CB) transplantation. However, how to prioritize these characteristics in unit selection is not established. Therefore, we analyzed the outcomes of 1061 patients who received single-unit myeloablative CB transplantation for leukemia or myelodysplasia. TNC dose and HLA-match each affected survival via their effect on transplant-related mortality (TRM); neither was associated with relapse. Therefore, TRM was the focus of multivariate analyses combining dose and HLA-match. Compared with our 1 HLA-mismatch (MM) reference group with TNC 2.5 to 4.9 x 10(7)/kg, recipients of 0 MM units had the lowest TRM regardless of dose (relative risk [RR] = 0.4, P = .019). TRM for recipients of 1- or 2-MM units with TNC 5.0 x 10(7)/kg or greater was similar to the reference group (RR = 0.8, P = .391 and RR = 1.0, P = .847) despite their greater dose. Recipients of 2 MM units with TNC 2.5 to 4.9 x 10(7)/kg had a greater TRM (RR = 1.5, P = .014), and those with 1 or 2 MM and TNC less than 2.5 x 10(7)/kg or 3 MM did substantially worse. These findings support new unit selection criteria that take into account both TNC dose and HLA-match and have important implications for the size of the global CB inventory needed to find an optimum CB graft.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The cumulative incidence (CI) of neutrophil engraftment by day 77 in patients given units with 0-MM (mean TNC, 4.4) or 3-MM (mean TNC, 3.9), or according to the TNC ×107/kg in patients with 1- or 2-MM CB grafts. Note that the 4 TNC categories in this figure exclude those that had either 0 or 3 mismatches, accounting for the lower number of cases in each TNC group in the figure compared with Table 2.
Figure 2
Figure 2
CI of grades 3 to 4 aGVHD according to HLA-mismatch.
Figure 3
Figure 3
CI of relapse according to HLA-mismatch.
Figure 4
Figure 4
CI of 3-year TRM. Data are shown by TNC dose (A), HLA-mismatch (B), TNC dose and HLA-mismatch combined (C), and the Kaplan-Meier probability of disease-free survival (D). Recipients of units with either 1 or 2 mismatches were analyzed by separate TNC dose categories, whereas recipients of 0-MM units and 3-MM units were not.
See this image and copyright information in PMC

References

    1. Gluckman E, Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol. 2006;18(5):565–570. - PubMed
    1. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol. 2007;137(1):20–35. - PubMed
    1. Barker JN. Umbilical cord blood transplantation: an alternative to the use of unrelated volunteer donors? Hematol Am Soc Hematol Educ Program. 2007:55–61. - PubMed
    1. Eapen M, Rubinstein P, Zhang MJ, et al. Comparison of outcomes after transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia. Lancet. 2007;369(9577):1947–1954. - PubMed
    1. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339(22):1565–1577. - PubMed

MeSH terms